Mutations in the CBP gene have been reported in approximately half of the RSTS patients [117], [118], whereas mutations in the p300 gene are estimated to represent 5%–8% of all cases [119], [120], [121], [122], [123], [124]. The gene discussed is CREBBP; the disease is Rubinstein-Taybi syndrome.